Install
Cancellations, Closures & Delays Meet Our Marketing Gurus Green Gold Fan Zone Never Forgotten Honor Flight Grand Theater 2025-26 Season ↪ How to Listen: Apps & Smart Speakers!
- 4,237articles · 30d
- 4+ hour agolatest article
- Aug 15, 2026earliest in window
- 15%with images
- 271avg words
- business 1,489
- world 1,230
- world news 1,119
- sports 955
- politics 947
- (midwest communications 703
- donald trump 649
- markets 613
- mc complete - state & national 598
- conservative talk 597
- brian kilmeade 552
- clay travis 508
- buck sexton 471
- sean hannity 441
- technology 434
- economy 413
- mark levin 404
- finance 389
- joe pags 364
- ap sports news 338
- News 1,390
- Economy, Business & Finance 1,334
- Politics 1,052
- Finance & Business 1,051
- Sports & Fitness 934
- Sports 929
- Sport 852
- Sensitive Subjects 670
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
US FDA approves Scholar Rock’s muscle weakness drug
2+ day, 15+ hour ago (80+ words) Sept 11 (Reuters) - The U.S. Food and Drug Administration on Friday approved Scholar Rock's therapy to treat a rare genetic condition that causes muscle weakness. (Reporting by Sneha S K in Bengaluru; Editing by Tasim Zahid)... US FDA approves Scholar…...
Astrazeneca’s breast cancer drug fails late-stage trial
2+ day, 15+ hour ago (77+ words) Sept 11 (Reuters) - AstraZeneca said on Friday its breast cancer drug failed to meet the main goal of improving progression-free survival during a late-stage trial. (Reporting by Christy Santhosh in Bengaluru; Editing by Tasim Zah... Astrazeneca’s breast cancer drug fails late-stage…...
Novo Nordisk says Wegovy approved in China for liver disease MASH
4+ day, 4+ hour ago (146+ words) STOCKHOLM, Sept 10 (Reuters) - Denmark's Novo Nordisk said on Thursday its blockbuster weight-loss drug Wegovy had been approved in China as the first GLP-1 RA class of drugs for the treatment of metabolic dysfunction-associated steatohepatitis... STOCKHOLM, Sept 10 (Reuters) â Denmarkâs…...
Health Rounds: AstraZeneca drug reduces lung disease flare-ups in late-stage trials
5+ day, 1+ hour ago (872+ words) Sept 9 (Reuters) – Today we feature data from studies being presented at the ongoing European Respiratory Society Congress in Barcelona. A drug being developed by AstraZeneca significantly reduced flare-ups of chronic obstructive pulmonary disease in two late-stage trials, researchers reported on…...
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
5+ day, 19+ hour ago (317+ words) Sept 8 (Reuters) – Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis’ treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns about the prospects of similar therapies for the tough-to-treat rare disease. Dyne’s stock led declines…...
Novartis announces trial setback on del-desiran drug
6+ day, 6+ hour ago (176+ words) ZURICH, Sept 8 (Reuters) – Swiss drugmaker Novartis on Tuesday said a late-stage study assessing drug del-desiran’s impact on myotonic dystrophy, a form of muscle wasting, had not met its target on a key metric, but reaffirmed its sales guidance through 2030. Novartis…...
GoodRx offers health subscription for families, to launch as employee benefit in 2027
1+ week, 3+ day ago (326+ words) NEW YORK, Sept 3 (Reuters) – GoodRx, a prescription drug savings site, announced on Thursday a family healthcare subscription for access to common medical services and over 250 medications, and it plans to launch the program as part of employer health benefits in…...
Alumis eyes late-stage lupus study despite trial miss
1+ week, 5+ day ago (295+ words) Sept 1 (Reuters) – Alumis said on Tuesday it plans to advance its experimental drug for a type of immunity-related condition in a smaller subset of patients, even after the treatment failed to meet the main goal of a mid-stage trial. Its…...
Novo Nordisk launches Wegovy weight-loss pill in Germany
1+ week, 6+ day ago (356+ words) COPENHAGEN, Sep 1 (Reuters) – Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday, with investors keenly focused on the oral weight-loss treatment in light of intensifying competition with U.S. rival Eli…...
Eli Lilly launches oral weight-loss pill Foundayo in UK | WSAU News/Talk 550 AM · 99.9 FM | Wausau, Stevens Point
3+ week, 13+ hour ago (168+ words) Aug 24 (Reuters) – Eli Lilly said on Monday it has launched its oral pill, Foundayo, in the UK for weight management and type 2 diabetes, making it the first country in Europe where the treatment is available. • The pill, known chemically as…...